ATE266424T1 - Coumarin und damit verwandte aromatische polymere prodrugs - Google Patents

Coumarin und damit verwandte aromatische polymere prodrugs

Info

Publication number
ATE266424T1
ATE266424T1 AT99933882T AT99933882T ATE266424T1 AT E266424 T1 ATE266424 T1 AT E266424T1 AT 99933882 T AT99933882 T AT 99933882T AT 99933882 T AT99933882 T AT 99933882T AT E266424 T1 ATE266424 T1 AT E266424T1
Authority
AT
Austria
Prior art keywords
substituted
zero
moiety
alkyls
heteroalkyls
Prior art date
Application number
AT99933882T
Other languages
German (de)
English (en)
Inventor
Richard B Greenwald
Yun H Choe
Annapurna Pendri
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Inc filed Critical Enzon Inc
Application granted granted Critical
Publication of ATE266424T1 publication Critical patent/ATE266424T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99933882T 1998-07-13 1999-07-12 Coumarin und damit verwandte aromatische polymere prodrugs ATE266424T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/114,860 US6214330B1 (en) 1998-07-13 1998-07-13 Coumarin and related aromatic-based polymeric prodrugs
PCT/US1999/015652 WO2000002568A1 (en) 1998-07-13 1999-07-12 Coumarin and related aromatic-based polymeric prodrugs

Publications (1)

Publication Number Publication Date
ATE266424T1 true ATE266424T1 (de) 2004-05-15

Family

ID=22357836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933882T ATE266424T1 (de) 1998-07-13 1999-07-12 Coumarin und damit verwandte aromatische polymere prodrugs

Country Status (9)

Country Link
US (1) US6214330B1 (enExample)
EP (1) EP1102592B1 (enExample)
JP (1) JP4999226B2 (enExample)
AT (1) ATE266424T1 (enExample)
AU (1) AU4983999A (enExample)
CA (1) CA2336663C (enExample)
DE (1) DE69917281T2 (enExample)
DK (1) DK1102592T3 (enExample)
WO (1) WO2000002568A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
US7534902B2 (en) * 2003-11-14 2009-05-19 Wisconsin Alumni Research Foundation Fluorescence assays with improved sensitivity
US20090214472A1 (en) * 2004-03-01 2009-08-27 Enzon Pharmaceuticals Inc. Interferon-beta polymer conjugates
JP2007533750A (ja) * 2004-04-21 2007-11-22 アルザ コーポレイション 緩和なチオール分解条件下で遊離可能なポリマー結合体
MXPA06012144A (es) * 2004-04-21 2007-01-31 Alza Corp Conjugado polimerico liberable bajo condiciones tioliticas suaves.
US8367065B2 (en) * 2006-09-15 2013-02-05 Enzon Pharmaceuticals, Inc. Targeted polymeric prodrugs containing multifunctional linkers
JP2010503708A (ja) * 2006-09-15 2010-02-04 エンゾン ファーマスーティカルズ インコーポレイテッド 多官能性リンカーを含む標的化ポリマープロドラッグ
CA2693645A1 (en) * 2007-07-11 2009-01-15 Enzon Pharmaceuticals, Inc. Polymeric drug delivery systems containing an aromatic allylic acid
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
US20100227327A1 (en) * 2008-08-08 2010-09-09 Xiaoliang Sunney Xie Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides
US20100036110A1 (en) * 2008-08-08 2010-02-11 Xiaoliang Sunney Xie Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides
JP6747971B2 (ja) 2013-10-15 2020-08-26 シアトル ジェネティックス, インコーポレイテッド 改善されたリガンド−薬物コンジュゲート薬物動態のためのpeg化薬物−リンカー
US11229708B2 (en) 2015-12-04 2022-01-25 Seagen Inc. Conjugates of quaternized tubulysin compounds
US11793880B2 (en) 2015-12-04 2023-10-24 Seagen Inc. Conjugates of quaternized tubulysin compounds
EP3433278A4 (en) 2016-03-25 2019-11-06 Seattle Genetics, Inc. METHOD FOR THE PRODUCTION OF PEGYLATED ACTIVE LINKERS AND INTERMEDIATE PRODUCTS THEREOF
CN110430901B (zh) 2017-03-24 2024-08-16 西雅图基因公司 制备葡糖苷酸药物-接头及其中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
FR2676058B1 (fr) 1991-04-30 1994-02-25 Hoechst Lab Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
EP0727992A4 (en) * 1993-10-20 2001-01-31 Enzon Inc SUBSTITUTED TAXOID SUBSTANCES IN 2 'AND / OR 7' POSITION
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
ES2227536T3 (es) 1995-06-27 2005-04-01 Pharmachemie B.V. Nuevos profarmacos de antraciclina, procedimiento de preparacion asi como su uso en quimioterapia selectiva.
JPH1087815A (ja) * 1996-08-22 1998-04-07 Enzon Inc ポリアルキレンオキシドカルボン酸の改良製造方法
EP0961619A4 (en) 1996-09-27 2001-09-26 Bristol Myers Squibb Co HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS

Also Published As

Publication number Publication date
JP2002520288A (ja) 2002-07-09
AU4983999A (en) 2000-02-01
EP1102592A1 (en) 2001-05-30
WO2000002568A1 (en) 2000-01-20
CA2336663C (en) 2009-10-20
CA2336663A1 (en) 2000-01-20
US6214330B1 (en) 2001-04-10
DE69917281D1 (de) 2004-06-17
DE69917281T2 (de) 2005-06-30
DK1102592T3 (da) 2004-08-16
JP4999226B2 (ja) 2012-08-15
EP1102592A4 (en) 2001-12-19
EP1102592B1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
ATE266424T1 (de) Coumarin und damit verwandte aromatische polymere prodrugs
AU2021299A (en) Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
BR9813480A (pt) Compostos inibidores de neuraminidase de ciclopentano substituìdo, composição e métodos de inibição da neuraminidase do vìrus da influenza- e de tratamento de infecção por vìrus da influenza-
TW377370B (en) Waterborne fluoropolymer solutions for treating hard surfaces
DK0648238T3 (da) Poly(3-hydroxyalkanoater) og fremgangsmåde til deres fremstilling
NO20005714D0 (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
ATE277012T1 (de) Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress
CO4950619A1 (es) Derivados de acido arilsulfonil hidroxamico
ATE281481T1 (de) Zusammensetzungen, enthaltend aminische antioxidantien auf basis von n-(4- anilinophenyl)amiden
NO940610L (no) Oksazolidinedionderivater, deres fremstilling og anvendelse
NO953447D0 (no) Nye 4-aminopyridiner, fremgangsmåte for deres fremstilling samt legemidler inneholdende disse
TR199902056T2 (xx) Heteroaril-Heksanoik asit amid t�revleri.
DK1265606T3 (da) Celleadhæsionsinhibitorer
HUP0301387A2 (hu) Szintetikus módszerek aplidin és új tumorellenes származékok előállítására
YU71091A (sh) Antiinflamatorne hidroksamske kiseline i n-hidroksikarbamidi
DK1379257T3 (da) Anticancer-profarmakon anvendende substituerede aromatiske syrer
NO995594D0 (no) Nye substituerte heterocykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO307175B1 (no) O-Acyl-4-fenyl-cykloalkanoler, deres salter, legemidler som inneholder disse forbindelser og deres anvendelse
ATE271542T1 (de) 2-thiocarbamoyloxy- und 2-carbamoyloxy-derivate von cyclopentyl-heptan(en)säure als therapeutische mittel
DK623486A (da) Guanidinobenzoesyreesterderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
AR037342A1 (es) Sulfonamidas ciclicas, inhibidores del factor xa de la coagulacion
ES2053018T3 (es) Tetrapeptido ciclico y procedimiento para su preparacion.
CO5060509A1 (es) 2-aminopiridinas que contienen sustituyentes de anillos condensados
NO20052598L (no) Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem.
DK0904270T3 (da) Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties